2007
Press/Media Releases:
CYTOCHROMA INITIATES
PHASE I/II CLINICAL TRIAL OF CTAP101 CAPSULES FOR VITAMIN
D INSUFFICIENCY IN CHRONIC KIDNEY DISEASE
November 20, 2007
CYTOCHROMA ANNOUNCES
APPOINTMENT OF GORDON NGAN, CFA, MBA AS EXECUTIVE DIRECTOR, CORPORATE
DEVELOPMENT
August 23, 2007
JOEL
Z. MELNICK, MD JOINS CYTOCHROMA AS VICE PRESIDENT, CLINICAL & REGULATORY
AFFAIRS
August 13, 2007
CYTOCHROMA REPORTS POSITIVE
PHASE I CLINICAL DATA FOR CTA018 INJECTION
June 28, 2007
CYTOCHROMA AND GENZYME
SETTLE LAWSUIT
April 16, 2007
CYTOCHROMA INC.
ANNOUNCES COMPLETION OF $3 MILLION RAISE
March 29, 2007
CYTOCHROMA APPOINTS
CO-FOUNDER DR. P. MARTIN PETKOVICH AS FULL-TIME CHIEF SCIENTIFIC
OFFICER
March 12, 2007
CYTOCHROMA COMPLETES
ENROLLMENT IN PHASE II PSORIASIS TRIAL
March 06, 2007
CYTOCHROMA INC.
ANNOUNCES COMPLETION OF $21 MILLION FINANCING ROUND
January 17, 2007
CYTOCHROMA
INC. AND AOVATECHNOLOGIES, INC., SIGN LICENSE AGREEMENT
January 8, 2007 |